期刊文献+

^(99m)Tc-MIBI与^(99m)Tc-PPM肺肿瘤阳性显像的对比研究 被引量:2

Compare the effectiveness of scintigraphy in technetium-99m-sestamibi with in technetium-99m-peplomycin in patients with benign and malignant lesion in the lung
下载PDF
导出
摘要 目的:对比分析99mTc-甲氧基异丁基异睛(MIBI)与99mTc-培普利欧霉素(PPM)肺肿瘤显像的特点与诊断效能。方法:对48例使用99mTc-MIBI与39例使用99Tc-PPM肿瘤阳性显像的结果通过目测观察,T/N(肿瘤与非肿瘤)比值测定,储存指数RI测定,延迟显像摄取指数DUI测定并对其结果进行对比。结果:目测观察,99mTc-MIBI显像对恶性肿瘤诊断的灵敏度为94.12%(32/34),特异性为85.71%(12/14),99mTc-PPM显像对恶性肿瘤诊断的灵敏度为90.91%(30/33),特异性为83.33%(5/6),两者之间无显著性差异(P>0.05);99mTc-MIBI在恶性肿瘤组早期T/N为1.36,晚期T/N为1.37,RI值为0.74DUI值为1.38,而99mTc-PPM在恶性肿瘤组分别为1.13,1.3611.77及1.64,其中两组早期T/N之间,晚期T/N之间均无显著性差异(P>0.05),两组RI值之间有非常显著性差异(P<0.01),两组DUI之间有显著性差异(P<0.05);两种显像剂在良性病变组各参数之间的差异均无显著性(P>0.05)。结论:99mTc-L-MIBI及99mTc-PPM肺肿瘤阳性显像对肺肿瘤的诊断及鉴别其良恶性有一定价值;恶性肿瘤对两种显像剂的外排存在差异。 Objective: To compare the effectiveness of scintigraphy in technetium - 99m - sestamibi (MIBI) with in technetium - 99m -peplomycin(PPM) in patients with benign and malignant lesion in the lung.Methods: The scintigraphy was performed with technetium99m-MIBI in 48 patients and technetium - 99m - PPM in 39 patients with pulmonary lesions .In this study, the imagin results were analyzed and the early and delayed tumor - to - normal lung uptake raio(T/N)were measaured and the retention index(RI) and the delayed uptake index(DUI) were calculated.Then above Parameters were compared between in technetium - 99m - MIBI and in technetium - 99m -PPM. Results: The sensitivity, specificity and accuuacy for technetium - 99m - MIBI scintigraphy were 94. 12%, 85. 71 % and 91. 67%, fortechnetium - 99m - PPM scintigraphy 90. 91 %, 83. 33% and 89. 74%. There was no significant difference in the sensitivity, specificity andaccuracy among the two scintigraphys(P > 0. 05). In malignant lesion group, the early T/N, delayed T/N, RI and DUI for technetium -99m - MIBl scintigraphy were 1. 36, 1. 37, 0. 74 and 1. 38, for technetiam - 99m - PPM scintgraphy 1.13, 1. 36, 11. 77 and 1. 64. Therewas no significant difference in the early T/N and delayed T/N among the two scintigraphys(P > 0.05) and there was significant low in RI (P< 0. 01) and DUI (P < 0. 05)for technetium - 99m - MIBI scintigraphy that wer compared with those for technetium - 99m - PPM scintigraphy. In the benign lesion group, there was no significant difference in the early T/N, delayed T/N, RI and DUI between in technetium -99m - MIBI scintigraphy and in technetitun - 99m - PPM scintigraphy(P > 0. 05). Conclusions: The both scintgraphys in technetium -99m - MIBl and in technetium - 99m - PPM seem to be good candidaet for noninvasive methods to diagnose pulmonary neoplasm and to distinguish between benign and malignant lesion in the lung.Some lung neoplasm cells extruded more technetium - 99m - MIBI than technetium - 99m - PPM.
出处 《中国临床医学影像杂志》 CAS 1999年第4期233-235,共3页 Journal of China Clinic Medical Imaging
关键词 肺肿瘤 肿瘤多耐药基因 Tc99m-MIBI Lung neoplasm Technetium-99m-sestamibi Technetium-99m-peplomycin Drug resistance, neoplasm
  • 相关文献

参考文献2

二级参考文献6

  • 1蒋宁一,核技术,1994年,17卷,284页
  • 2蒋宁一,放射性核素内放射治疗骨转移瘤影像诊断与介入放射学,1993年,156页
  • 3赵惠扬,核医学,1981年
  • 4李军,中国医学科学院学报,1995年,17卷,276页
  • 5周前,中华核医学杂志,1991年,11卷,217页
  • 6施绪保,中华核医学杂志,1990年,10卷,1页

共引文献7

同被引文献14

  • 1刘宝国,徐光炜,张梅颖,李吉友,金懋林,林宝和,李振南,吴健,许小宝,董志伟.胃癌放射免疫导向手术的研究[J].中华肿瘤杂志,1994,16(4):284-287. 被引量:11
  • 2Schlomo S, Einat ES, Meir C, et al. Clinical applicationsof gamma-detection probes: radioguided surgery. Eur J Nucl Med,1999, 26 (Suppl): S26-S35.
  • 3Arnold MW, Yong DC, Hitchcock CL, et al. Radioimmunoguided surgery in primary colorectal carcinoma: an intraoperative prognostic tool and adjuvant to traditional staging. Am J Surg,1995, 170: 315-318.
  • 4Fleshman JW, Conner JW, Neufeld DW, et al. Tumorlocalization and radioimmunoimaging with mixture of radioiodinedmonoclonal antibodies directed to different colon cancer associatedantigens. Nucl Med Biol, 1992, 19: 659-668.
  • 5Hayashi N, Arakawa H. Nagase H, et al. Genetic diagnosis identigies occult lymph node metastasis undetectable by thehistopathologic method. Cancer Res, 1994, 54: 3853-3856.
  • 6Muller S, Guth-Tougelidis B, Greutzig H, et al. Imagingof malignant tumors with Tc-99m-MIBI SPECT. J Nucl Med,1987, 28: 562.
  • 7Muller SP, Reiners C, Paas M, et al. Tc-99m MIBI andT1-201 uptake in bronchial carcinoma. J Nucl Med, 1989, 30:845.
  • 8Ernest KJ, Pauwels V, Ralph M, et al. The mechanism ofaccumulation of tumour-localising radiopharmaceuticals. Eur J NuclMed, 1998, 25: 277-305.
  • 9Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellulardistribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med, 1992, 33: 1516-1522.
  • 10Maffioli L, Steens J, Pauwels E, et al. Applications of99m-Tc-sestamibi in oncology. Tumori, 1996, 82: 12-21.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部